Menu

Appendectomy or JAK inhibitor in Active UC; Upadacitinib Benefit–Risk Profile

Article |

dusktinker09 24d ago
Appendectomy or JAK inhibitor in Active UC; Upadacitinib Benefit–Risk Profile

The first study in the The Regueiro Report this month is extremely exciting, as...

Comments (0)

Newest

No comments yet.